News | August 27, 2015

Receive Case Studies From Merck Serono, Teva, MHRA, Cinfa Biotech GmbH, Selecta Biosciences, Norwegian Medicines Agency And More | Biosimilars And Biobetters

Biosimilars and Biobetters

LONDON (PRWEB UK) - SMi's 6th annual Biosimilars and Biobetters conference will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance through technical case studies and practical advice from leading biosimilar and regulatory players from organisations including Harvest Moon Pharmaceuticals USA Inc, GfK, Selecta Biosciences, Cinfa Biotech GmbH, Norwegian Medicines Agency and more. Unique perspectives will be shared on: 
Evolving biosimilar regulatory landscape 
Market access and product commercialisation barriers 
How advanced structural characterisation techniques can support regulatory approval 
How to engage payers and clinicians on safety and adoption of Biosimilars and Biobetters

Speaker Panel includes: 
Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc. 
Shahin Kauser, Senior Scientific Assessor, MHRA 
Chris Teale, Vice President Europe, GfK NOP Ltd 
Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva 
Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences 
Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH 
Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health 
Steinar Madsen, Medical Director, Norwegian Medicines Agency

To view the full speaker line-up and complete conference programme, visit http://www.biosimilars-biobetters.co.uk/prweb

Plus, don't miss the interactive conference workshops:

A: Assessing the Regulatory Framework for Europe and the US – Developing Future Biologics 
Led by: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP | 29th September 2015, 13.30 - 17.30

B: Biosimilars – Understanding the Regulatory Processes and the Commercial Realities 
Led by: Peter Wittner, Senior Consultant, Interpharm Consultancy | 2nd October 2015, 08.30 - 12.30

Source: PRWeb

View original release here: http://www.prweb.com/releases/biosimilars/biobetters/prweb12925354.htm